• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

膜增生性肾小球肾炎:发病机制的异质性和新分类的建议。

Membranoproliferative glomerulonephritis: pathogenetic heterogeneity and proposal for a new classification.

机构信息

Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota 55905, USA.

出版信息

Semin Nephrol. 2011 Jul;31(4):341-8. doi: 10.1016/j.semnephrol.2011.06.005.

DOI:10.1016/j.semnephrol.2011.06.005
PMID:21839367
Abstract

Membranoproliferative glomerulonephritis (MPGN) is a pattern of injury that results from subendothelial and mesangial deposition of Igs caused by persistent antigenemia and/or circulating immune complexes. The common causes of Ig-mediated MPGN include chronic infections, autoimmune diseases, and monoclonal gammopathy/dysproteinemias. On the other hand, MPGN also can result from subendothelial and mesangial deposition of complement owing to dysregulation of the alternative pathway (AP) of complement. Complement-mediated MPGN includes dense deposit disease and proliferative glomerulonephritis with C3 deposits. Dysregulation of the AP of complement can result from genetic mutations or development of autoantibodies to complement regulating proteins with ensuing dense deposit disease or glomerulonephritis with C3 deposits. We propose a new histologic classification of MPGN and classify MPGN into 2 major groups: Ig-mediated and complement-mediated. MPGN that is Ig-mediated should lead to work-up for infections, autoimmune diseases, and monoclonal gammopathy. On the other hand, complement-mediated MPGN should lead to work-up of the AP of complement. Initial AP screening tests should include serum membrane attack complex levels, an AP functional assay, and a hemolytic assay, followed by tests for mutations and autoantibodies to complement-regulating proteins.

摘要

膜增生性肾小球肾炎 (MPGN) 是一种损伤模式,由持续性抗原血症和/或循环免疫复合物引起的内皮下和系膜沉积 Ig 导致。Ig 介导的 MPGN 的常见原因包括慢性感染、自身免疫性疾病和单克隆丙种球蛋白病/蛋白血症。另一方面,MPGN 也可能由于补体替代途径 (AP) 的失调导致补体在内皮下和系膜沉积。补体介导的 MPGN 包括致密物沉积病和 C3 沉积的增殖性肾小球肾炎。补体 AP 的失调可由基因突变或针对补体调节蛋白的自身抗体的发展引起,随后发生致密物沉积病或 C3 沉积的肾小球肾炎。我们提出了一种新的 MPGN 组织学分类,并将 MPGN 分为 2 大主要组:Ig 介导和补体介导。由 Ig 介导的 MPGN 应进行感染、自身免疫性疾病和单克隆丙种球蛋白病的检查。另一方面,补体介导的 MPGN 应进行补体 AP 的检查。初始 AP 筛选测试应包括血清膜攻击复合物水平、AP 功能测定和溶血测定,然后是补体调节蛋白的突变和自身抗体测试。

相似文献

1
Membranoproliferative glomerulonephritis: pathogenetic heterogeneity and proposal for a new classification.膜增生性肾小球肾炎:发病机制的异质性和新分类的建议。
Semin Nephrol. 2011 Jul;31(4):341-8. doi: 10.1016/j.semnephrol.2011.06.005.
2
Hereditary and acquired complement dysregulation in membranoproliferative glomerulonephritis.膜增生性肾小球肾炎中的遗传性和获得性补体调节异常。
Thromb Haemost. 2009 Feb;101(2):271-8.
3
Primary glomerulonephritis with isolated C3 deposits: a new entity which shares common genetic risk factors with haemolytic uraemic syndrome.伴有孤立性C3沉积的原发性肾小球肾炎:一种与溶血尿毒综合征具有共同遗传风险因素的新实体。
J Med Genet. 2007 Mar;44(3):193-9. doi: 10.1136/jmg.2006.045328. Epub 2006 Oct 3.
4
Membranoprolferative glomerulonephritis - mechanisms and treatment.膜增生性肾小球肾炎——发病机制与治疗
Contrib Nephrol. 2013;181:163-74. doi: 10.1159/000348635. Epub 2013 May 8.
5
Histopathology of MPGN and C3 glomerulopathies.MPGN 和 C3 肾小球病的组织病理学。
Nat Rev Nephrol. 2015 Jan;11(1):14-22. doi: 10.1038/nrneph.2014.217. Epub 2014 Dec 2.
6
Unraveling the Molecular Mechanisms Underlying Complement Dysregulation by Nephritic Factors in C3G and IC-MPGN.阐明 C3G 和 IC-MPGN 中肾炎因子导致补体失调的分子机制。
Front Immunol. 2018 Oct 15;9:2329. doi: 10.3389/fimmu.2018.02329. eCollection 2018.
7
Proliferative glomerulonephritis secondary to dysfunction of the alternative pathway of complement.补体旁路功能失调所致增生性肾小球肾炎。
Clin J Am Soc Nephrol. 2011 May;6(5):1009-17. doi: 10.2215/CJN.07110810. Epub 2011 Mar 17.
8
Autoimmune abnormalities of the alternative complement pathway in membranoproliferative glomerulonephritis and C3 glomerulopathy.补体替代途径自身免疫异常在膜增生性肾小球肾炎和 C3 肾小球病中的作用。
Pediatr Nephrol. 2019 Aug;34(8):1311-1323. doi: 10.1007/s00467-018-3989-0. Epub 2018 Jun 9.
9
Idiopathic membranoproliferative glomerulonephritis: does it exist?特发性膜性增生性肾小球肾炎:是否存在?
Nephrol Dial Transplant. 2012 Dec;27(12):4288-94. doi: 10.1093/ndt/gfs288. Epub 2012 Jul 13.
10
Complement gene variants determine the risk of immunoglobulin-associated MPGN and C3 glomerulopathy and predict long-term renal outcome.补体基因变异决定免疫球蛋白相关MPGN和C3肾小球病的风险,并预测长期肾脏结局。
Mol Immunol. 2016 Mar;71:131-142. doi: 10.1016/j.molimm.2016.01.010. Epub 2016 Feb 16.

引用本文的文献

1
Elusive Edema: A Case of Nephrotic Syndrome Mimicking Decompensated Cirrhosis.隐匿性水肿:一例酷似失代偿期肝硬化的肾病综合征病例
Fed Pract. 2025 Jun;42(6):230-234. doi: 10.12788/fp.0593. Epub 2025 Jun 16.
2
Nephrotic syndrome after switching from irinotecan, S-1, and bevacizumab combination to trifluridine/tipiracil.从伊立替康、S-1和贝伐单抗联合用药转换为曲氟尿苷/替匹嘧啶后出现的肾病综合征。
CEN Case Rep. 2025 Jul 10. doi: 10.1007/s13730-025-01014-0.
3
A rare case of coronin-1A deficiency with IgM dominant membranoproliferative glomerulonephritis.
1例罕见的伴有IgM为主的膜增生性肾小球肾炎的coronin-1A缺乏症病例。
CEN Case Rep. 2025 Jun 4. doi: 10.1007/s13730-025-01004-2.
4
Fatal Outcome of Membranoproliferative Glomerulonephritis in a Patient With Hidden Visceral Leishmaniasis.隐匿性内脏利什曼病患者发生膜增生性肾小球肾炎的致命结局
Case Rep Infect Dis. 2025 May 19;2025:3448351. doi: 10.1155/crdi/3448351. eCollection 2025.
5
Repeated Kidney Biopsy in Membranoproliferative Glomerulonephritis.膜增生性肾小球肾炎的重复肾活检
Kidney Dis (Basel). 2025 Apr 4;11(1):258-269. doi: 10.1159/000545727. eCollection 2025 Jan-Dec.
6
Pathogenesis of Focal Segmental Glomerulosclerosis and Minimal Change Disease: Insights from Glomerular Proteomics.局灶节段性肾小球硬化症和微小病变病的发病机制:肾小球蛋白质组学的见解
Life (Basel). 2025 Mar 23;15(4):527. doi: 10.3390/life15040527.
7
Expert Discussion on Immune Complex-Mediated Membranoproliferative Glomerulonephritis: Challenges and Considerations.免疫复合物介导的膜增生性肾小球肾炎专家讨论:挑战与思考
Adv Ther. 2025 May;42(5):2003-2014. doi: 10.1007/s12325-025-03167-x. Epub 2025 Mar 27.
8
Challenges in the Diagnosis and Management of Immune Complex-Mediated Membranoproliferative Glomerulonephritis and Complement 3 Glomerulopathy.免疫复合物介导的膜增生性肾小球肾炎和补体3肾小球病的诊断与管理挑战
Kidney Int Rep. 2024 Sep 21;10(1):17-28. doi: 10.1016/j.ekir.2024.09.017. eCollection 2025 Jan.
9
A Case Report of Membranoproliferative Glomerulonephritis: Infection-Related or Immune-Related?膜增生性肾小球肾炎病例报告:感染相关性还是免疫相关性?
Clin Case Rep. 2025 Jan 6;13(1):e70088. doi: 10.1002/ccr3.70088. eCollection 2025 Jan.
10
Immunofluorescence Use and Techniques in Glomerular Diseases: A Review.肾小球疾病中免疫荧光的应用与技术:综述
Glomerular Dis. 2024 Nov 11;4(1):227-240. doi: 10.1159/000542497. eCollection 2024 Jan-Dec.